Skin equivalents: Skin from reconstructions as models to study skin development and diseases

British Journal of Dermatology

Volumn 173, Issue 2, 2015, Pages 391-403

  Ali, N ^a,b,c   Hosseini, M ^b,c   Vainio, S ^a   Taieb A ^b,c,d,e   Cario Andre M ^b,c,d   Rezvani, H R ^b,c,d  

^a UNIVERSITY OF OULU   (Finland)

^b Bordeaux Institute of Oncology   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d Centre de Référence Pour les Maladies Rares de la Peau   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BURN; CELL DIFFERENTIATION; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CULTURE TECHNIQUE; CYTOLOGY; DERMAL STEM CELL; DEVELOPMENTAL BIOLOGY; DOWN REGULATION; EPIDERMAL STEM CELL; EX VIVO STUDY; GENETIC ENGINEERING; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN SKIN EQUIVALENT; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MELANOCYTE; NONHUMAN; NUCLEAR REPROGRAMMING; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SKIN BIOLOGY; SKIN DISEASE; SKIN PIGMENTATION; SKIN RECONSTRUCTION; SKIN SURGERY; STEM CELL; TUMOR MICROENVIRONMENT; WOUND HEALING; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; CELL CULTURE TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; MOUSE; PATHOLOGY; PHOTOSENSITIVITY DISORDER; PHYSIOLOGY; SKIN;

ANIMALS; BURNS; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; HOMEOSTASIS; HUMANS; KERATINOCYTES; MELANOCYTES; MICE; MODELS, BIOLOGICAL; PHOTOSENSITIVITY DISORDERS; SKIN; SKIN DISEASES; STEM CELLS; WOUND HEALING;

EID: 84941173598     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13886     Document Type: Review

References (194)

1. Proksch E, Brandner JM, Jensen JM,. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063-72.
2. Burgeson RE, Christiano AM,. The dermal-epidermal junction. Curr Opin Cell Biol 1997; 9: 651-8.
3. Tobin DJ,. Biochemistry of human skin-our brain on the outside. Chem Soc Rev 2006; 35: 52-67.
4. Grinnell F,. Biochemical analysis of cell adhesion to a substratum and its possible relevance to cell metastasis. Prog Clin Biol Res 1976; 9: 227-36.
5. Bissell MJ, Hall HG, Parry G,. How does the extracellular matrix direct gene expression? J Theor Biol 1982; 99: 31-68.
6. Yang J, Balakrishnan A, Hamamoto S, et al,. Different mitogenic and phenotypic responses of human breast epithelial cells grown in two versus three dimensions. Exp Cell Res 1986; 167: 563-9.
7. Lin CQ, Bissell MJ,. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 1993; 7: 737-43.
8. Smalley KS, Lioni M, Herlyn M,. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 2006; 42: 242-7.
9. Grinnell F,. Fibroblast mechanics in three-dimensional collagen matrices. J Bodyw Mov Ther 2008; 12: 191-3.
10. Horning JL, Sahoo SK, Vijayaraghavalu S, et al,. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008; 5: 849-62.
11. Mazzoleni G, Di Lorenzo D, Steimberg N,. Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? Genes Nutr 2009; 4: 13-22.
12. Lu Z, Hasse S, Bodo E, et al,. Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 2007; 16: 37-44.
13. Yano S, Miwa S, Mii S, et al,. Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional gelfoam histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging. Cell Cycle 2015; 14: 808-19.
14. Li LN, Margolis LB, Hoffman RM,. Skin toxicity determined in vitro by three-dimensional, native-state histoculture. Proc Natl Acad Sci USA 1991; 88: 1908-12.
15. Hoffman RM,. The clinical benefit of the histoculture drug response assay. Gan To Kagaku Ryoho 2000; 27 (Suppl. 2): 321-2.
16. Hoffman RM,. Three-dimensional histoculture: origins and applications in cancer research. Cancer Cells 1991; 3: 86-92.
17. Hoffman RM, Connors KM, Meerson-Monosov AZ, et al,. A general native-state method for determination of proliferation capacity of human normal and tumor tissues in vitro. Proc Natl Acad Sci USA 1989; 86: 2013-17.
18. Li L, Paus R, Slominski A, et al,. Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev Biol 1992; 28A: 695-8.
19. Bagabir R, Syed F, Paus R, Bayat A,. Long-term organ culture of keloid disease tissue. Exp Dermatol 2012; 21: 376-81.
20. Wong VW, Sorkin M, Glotzbach JP, et al,. Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol 2011; 2011: 969618.
21. Cruickshank CN, Cooper JR, Hooper C,. The cultivation of cells from adult epidermis. J Invest Dermatol 1960; 34: 339-42.
22. Rheinwald JG, Green H,. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6: 331-43.
23. Freeman AE, Igel HJ, Herrman BJ, Kleinfeld KL,. Growth and characterization of human skin epithelial cell cultures. In Vitro 1976; 12: 352-62.
24. Lillie JH, MacCallum DK, Jepsen A,. Fine structure of subcultivated stratified squamous epithelium grown on collagen rafts. Exp Cell Res 1980; 125: 153-65.
25. Fusenig NE, Amer SM, Boukamp P, Worst PK,. Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo. Bull Cancer 1978; 65: 271-9.
26. Prunieras M, Regnier M, Woodley D,. Methods for cultivation of keratinocytes with an air-liquid interface. J Invest Dermatol 1983; 81: 28s-33s.
27. Gazel A, Ramphal P, Rosdy M, et al,. Transcriptional profiling of epidermal keratinocytes: comparison of genes expressed in skin, cultured keratinocytes, and reconstituted epidermis, using large DNA microarrays. J Invest Dermatol 2003; 121: 1459-68.
28. Poumay Y, Dupont F, Marcoux S, et al,. A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res 2004; 296: 203-11.
29. Poumay Y, Leclercq-Smekens M,. In vitro models of epidermal differentiation. Folia Med (Plovdiv) 1998; 40: 5-12.
30. Rosdy M, Clauss LC,. Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air-liquid interface. J Invest Dermatol 1990; 95: 409-14.
31. Asselineau D, Prunieras M,. Reconstruction of 'simplified' skin: control of fabrication. Br J Dermatol 1984; 111 (Suppl. 27): 219-22.
32. Bernerd F, Vioux C, Lejeune F, Asselineau D,. The sun protection factor (SPF) inadequately defines broad spectrum photoprotection: demonstration using skin reconstructed in vitro exposed to UVA, UVBor UV-solar simulated radiation. Eur J Dermatol 2003; 13: 242-9.
33. Rezvani HR, Cario-André M, Pain C, et al,. Protection of normal human reconstructed epidermis from UV by catalase overexpression. Cancer Gene Ther 2007; 14: 174-86.
34. Prunieras M, Regnier M, Schlotterer M,. [New procedure for culturing human epidermal cells on allogenic or xenogenic skin: preparation of recombined grafts]. Ann Chir Plast 1979; 24: 357-62 (in French).
35. Cario-André M, Briganti S, Picardo M, et al,. Epidermal reconstructs: a new tool to study topical and systemic photoprotective molecules. J Photochem Photobiol, B 2002; 68: 79-87.
36. Cario-André M, Pain C, Gall Y, et al,. Studies on epidermis reconstructed with and without melanocytes: melanocytes prevent sunburn cell formation but not appearance of DNA damaged cells in fair-skinned caucasians. J Invest Dermatol 2000; 115: 193-9.
37. Tinois E, Tiollier J, Gaucherand M, et al,. In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Exp Cell Res 1991; 193: 310-19.
38. Ponec M, Weerheim A, Kempenaar J, et al,. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997; 109: 348-55.
39. Hull BE, Sher SE, Rosen S, et al,. Fibroblasts in isogeneic skin equivalents persist for long periods after grafting. J Invest Dermatol 1983; 81: 436-8.
40. Pageon H, Bakala H, Monnier VM, Asselineau D,. Collagen glycation triggers the formation of aged skin in vitro. Eur J Dermatol 2007; 17: 12-20.
41. el-Ghalbzouri A, Gibbs S, Lamme E, et al,. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 2002; 147: 230-43.
42. Régnier M, Staquet MJ, Schmitt D, Schmidt R,. Integration of Langerhans cells into a pigmented reconstructed human epidermis. J Invest Dermatol 1997; 109: 510-12.
43. Régnier M, Patwardhan A, Scheynius A, Schmidt R,. Reconstructed human epidermis composed of keratinocytes, melanocytes and Langerhans cells. Med Biol Eng Comput 1998; 36: 821-4.
44. Phillips TJ,. New skin for old: developments in biological skin substitutes. Arch Dermatol 1998; 134: 344-9.
45. Régnier M, Duval C, Schmidt R,. Potential cosmetic applications of reconstructed epidermis. Int J Cosmet Sci 1999; 21: 51-8.
46. Wong T, McGrath JA, Navsaria H,. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 2007; 156: 1149-55.
47. Cooper ML, Hansbrough JF, Spielvogel RL, et al,. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991; 12: 243-8.
48. Smola H, Stark HJ, Thiekotter G, et al,. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res 1998; 239: 399-410.
49. Green H, Kehinde O, Thomas J,. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979; 76: 5665-8.
50. O'Connor N, Mulliken JB, Banks-Schlegel S, et al,. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; 317: 75-8.
51. Herzog SR, Meyer A, Woodley D, Peterson HD,. Wound coverage with cultured autologous keratinocytes: use after burn wound excision, including biopsy followup. J Trauma 1988; 28: 195-8.
52. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T,. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981; 211: 1052-4.
53. Burke JF, Yannas IV, Quinby WC Jr, et al,. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413-28.
54. Hansbrough JF, Boyce ST, Cooper ML, Foreman TJ,. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA 1989; 262: 2125-30.
55. Krejci NC, Cuono CB, Langdon RC, McGuire J,. In vitro reconstitution of skin: fibroblasts facilitate keratinocyte growth and differentiation on acellular reticular dermis. J Invest Dermatol 1991; 97: 843-8.
56. Medalie DA, Eming SA, Tompkins RG, et al,. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J Invest Dermatol 1996; 107: 121-7.
57. Ben-Bassat H, Eldad A, Chaouat M, et al,. Structural and functional evaluation of modifications in the composite skin graft: cryopreserved dermis and cultured keratinocytes. Plast Reconstr Surg 1992; 89: 510-20.
58. Gilhar A, Keren A, Paus R,. A new humanized mouse model for alopecia areata. J Investig Dermatol Symp Proc 2013; 16: S37-8.
59. Gilhar A, Ullmann Y, Berkutzki T, et al,. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998; 101: 62-7.
60. Wang CK, Nelson CF, Brinkman AM, et al,. Spontaneous cell sorting of fibroblasts and keratinocytes creates an organotypic human skin equivalent. J Invest Dermatol 2000; 114: 674-80.
61. Marinkovich MP, Keene DR, Rimberg CS, Burgeson RE,. Cellular origin of the dermal-epidermal basement membrane. Dev Dyn 1993; 197: 255-67.
62. Fleischmajer R, Kuhn K, Sato Y, et al,. There is temporal and spatial expression of alpha1 (IV), alpha2 (IV), alpha5 (IV), alpha6 (IV) collagen chains and beta1 integrins during the development of the basal lamina in an "in vitro" skin model. J Invest Dermatol 1997; 109: 527-33.
63. Latijnhouwers M, Bergers M, Ponec M, et al,. Human epidermal keratinocytes are a source of tenascin-C during wound healing. J Invest Dermatol 1997; 108: 776-83.
64. Nolte SV, Xu W, Rennekampff HO, Rodemann HP,. Diversity of fibroblasts-a review on implications for skin tissue engineering. Cells Tissues Organs 2008; 187: 165-76.
65. El Ghalbzouri A, Lamme E, Ponec M,. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 2002; 310: 189-99.
66. Fukunaga-Kalabis M, Martinez G, Liu ZJ, et al,. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 2006; 175: 563-9.
67. Santiago-Walker A, Li L, Haass NK, Herlyn M,. Melanocytes: from morphology to application. Skin Pharmacol Physiol 2009; 22: 114-21.
68. Valyi-Nagy IT, Murphy GF, Mancianti ML, et al,. Phenotypes and interactions of human melanocytes and keratinocytes in an epidermal reconstruction model. Lab Invest 1990; 62: 314-24.
69. Meier F, Nesbit M, Hsu MY, et al,. Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol 2000; 156: 193-200.
70. Bessou S, Surleve-Bazeille JE, Pain C, et al,. Ex vivo study of skin phototypes. J Invest Dermatol 1996; 107: 684-8.
71. Cario-André M, Pain C, Gauthier Y, et al,. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res 2006; 19: 434-42.
72. Okazaki M, Suzuki Y, Yoshimura K, Harri K,. Construction of pigmented skin equivalent and its application to the study of congenital disorders of pigmentation. Scand J Plast Reconstr Surg Hand Surg 2005; 39: 339-43.
73. Ni-Komatsu L, Tong C, Chen G, et al,. Identification of quinolines that inhibit melanogenesis by altering tyrosinase family trafficking. Mol Pharmacol 2008; 74: 1576-86.
74. Jain P, Sonti S, Garruto J, et al,. Formulation optimization, skin irritation, and efficacy characterization of a novel skin-lightening agent. J Cosmet Dermatol 2012; 11: 101-10.
75. Wang Z, Li X, Yang Z, et al,. Effects of aloesin on melanogenesis in pigmented skin equivalents. Int J Cosmet Sci 2008; 30: 121-30.
76. Duval C, Schmidt R, Regnier M, et al,. The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy. Exp Dermatol 2003; 12 (Suppl. 2): 64-70.
77. Duval C, Chagnoleau C, Pouradier F, et al,. Human skin model containing melanocytes: essential role of keratinocyte growth factor for constitutive pigmentation-functional response to alpha-melanocyte stimulating hormone and forskolin. Tissue Eng Part C Methods 2012; 18: 947-57.
78. Bernerd F, Marionnet C, Duval C,. Solar ultraviolet radiation induces biological alterations in human skin in vitro: relevance of a well-balanced UVA/UVB protection. Indian J Dermatol Venereol Leprol 2012; 78 (Suppl. 1): S15-23.
79. Archambault M, Yaar M, Gilchrest BA,. Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. J Invest Dermatol 1995; 104: 859-67.
80. Hedley SJ, Layton C, Heaton M, et al,. Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. Pigment Cell Res 2002; 15: 49-56.
81. Salducci M, André N, Guere C, et al,. Factors secreted by irradiated aged fibroblasts induce solar lentigo in pigmented reconstructed epidermis. Pigment Cell Melanoma Res 2014; 27: 502-4.
82. Imokawa G, Yada Y, Morisaki N, Kimura M,. Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes. Biochem J 1998; 330 (Pt. 3): 1235-9.
83. Kondo T, Hearing VJ,. Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Rev Dermatol 2011; 6: 97-108.
84. Yamaguchi Y, Itami S, Watabe H, et al,. Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol 2004; 165: 275-85.
85. Choi W, Miyamura Y, Wolber R, et al,. Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVB. J Invest Dermatol 2010; 130: 1685-96.
86. Yamaguchi Y, Passeron T, Hoashi T, et al,. Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes. FASEB J 2008; 22: 1009-20.
87. Yamaguchi Y, Hearing VJ,. Physiological factors that regulate skin pigmentation. BioFactors 2009; 35: 193-9.
88. Choi W, Wolber R, Gerwat W, et al,. The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin. J Cell Sci 2010; 123: 3102-11.
89. Watt FM, Jensen KB,. Epidermal stem cell diversity and quiescence. EMBO Mol Med 2009; 1: 260-7.
90. Driskell RR, Clavel C, Rendl M, Watt FM,. Hair follicle dermal papilla cells at a glance. J Cell Sci 2011; 124: 1179-82.
91. Liu S, Zhang H, Duan E,. Epidermal development in mammals: key regulators, signals from beneath, and stem cells. Int J Mol Sci 2013; 14: 10869-95.
92. Tadeu AM, Horsley V,. Epithelial stem cells in adult skin. Curr Top Dev Biol 2014; 107: 109-31.
93. Fuchs E, Horsley V,. More than one way to skin. Genes Dev 2008; 22: 976-85.
94. Fuchs E,. Skin stem cells: rising to the surface. J Cell Biol 2008; 180: 273-84.
95. Horsley V, O'Carroll D, Tooze R, et al,. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell 2006; 126: 597-609.
96. Blanpain C, Fuchs E,. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 2006; 22: 339-73.
97. Morris RJ, Liu Y, Marles L, et al,. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 2004; 22: 411-17.
98. Blanpain C, Lowry WE, Geoghegan A, et al,. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004; 118: 635-48.
99. Oshima H, Rochat A, Kedzia C, et al,. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 2001; 104: 233-45.
100. Plikus MV, Mayer JA, de la Cruz D, et al,. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature 2008; 451: 340-4.
101. Myung PS, Takeo M, Ito M, Atit RP,. Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration. J Invest Dermatol 2013; 133: 31-41.
102. Blanpain C, Fuchs E,. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 2009; 10: 207-17.
103. Yang L, Peng R,. Unveiling hair follicle stem cells. Stem Cell Rev 2010; 6: 658-64.
104. Kellner JC, Coulombe PA,. Preview. SKPing a hurdle: Sox2 and adult dermal stem cells. Cell Stem Cell 2009; 5: 569-70.
105. Driskell RR, Giangreco A, Jensen KB, et al,. Sox2-positive dermal papilla cells specify hair follicle type in mammalian epidermis. Development 2009; 136: 2815-23.
106. Biernaskie J, Paris M, Morozova O, et al,. SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell 2009; 5: 610-23.
107. Toma JG, Akhavan M, Fernandes KJ, et al,. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3: 778-84.
108. Fernandes KJ, McKenzie IA, Mill P, et al,. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082-93.
109. Toma JG, McKenzie IA, Bagli D, Miller FD,. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005; 23: 727-37.
110. Cohen J,. The transplantation of individual rat and guinea-pig whisker papillae. J Embryol Exp Morphol 1961; 9: 117-27.
111. Oliver RF,. The induction of hair follicle formation in the adult hooded rat by vibrissa dermal papillae. J Embryol Exp Morphol 1970; 23: 219-36.
112. Jahoda CA, Horne KA, Oliver RF,. Induction of hair growth by implantation of cultured dermal papilla cells. Nature 1984; 311: 560-2.
113. Kishimoto J, Burgeson RE, Morgan BA,. Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev 2000; 14: 1181-5.
114. Rendl M, Polak L, Fuchs E,. BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev 2008; 22: 543-57.
115. Higgins CA, Chen JC, Cerise JE, et al,. Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth. Proc Natl Acad Sci USA 2013; 110: 19679-88.
116. Li L, Fukunaga-Kalabis M, Yu H, et al,. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci 2010; 123: 853-60.
117. Li L, Fukunaga-Kalabis M, Herlyn M,. Isolation and cultivation of dermal stem cells that differentiate into functional epidermal melanocytes. Methods Mol Biol 2012; 806: 15-29.
118. Yamanishi H, Fujiwara S, Soma T,. Perivascular localization of dermal stem cells in human scalp. Exp Dermatol 2012; 21: 78-80.
119. Ma K, Laco F, Ramakrishna S, et al,. Differentiation of bone marrow-derived mesenchymal stem cells into multi-layered epidermis-like cells in 3D organotypic coculture. Biomaterials 2009; 30: 3251-8.
120. Jeremias T da S, Machado RG, Visoni SB, et al,. Dermal substitutes support the growth of human skin-derived mesenchymal stromal cells: potential tool for skin regeneration. PLoS One 2014; 9: e89542.
121. Ojeh NO, Navsaria HA,. An in vitro skin model to study the effect of mesenchymal stem cells in wound healing and epidermal regeneration. J Biomed Mater Res A 2014; 102: 2785-92.
122. Bilousova G, Chen J, Roop DR,. Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage. J Invest Dermatol 2011; 131: 857-64.
123. Tolar J, Xia L, Riddle MJ, et al,. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011; 131: 848-56.
124. Guenou H, Nissan X, Larcher F, et al,. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 2009; 374: 1745-53.
125. Itoh M, Kiuru M, Cairo MS, Christiano AM,. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA 2011; 108: 8797-802.
126. Itoh M, Umegaki-Arao N, Guo Z, et al,. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One 2013; 8: e77673.
127. Hewitt KJ, Shamis Y, Hayman RB, et al,. Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. PLoS One 2011; 6: e17128.
128. Nissan X, Larribere L, Saidani M, et al,. Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis. Proc Natl Acad Sci USA 2011; 108: 14861-6.
129. Safferling K, Sutterlin T, Westphal K, et al,. Wound healing revised: a novel reepithelialization mechanism revealed by in vitro and in silico models. J Cell Biol 2013; 203: 691-709.
130. Garlick JA, Taichman LB,. Fate of human keratinocytes during reepithelialization in an organotypic culture model. Lab Invest 1994; 70: 916-24.
131. Garlick JA, Parks WC, Welgus HG, Taichman LB,. Re-epithelialization of human oral keratinocytes in vitro. J Dent Res 1996; 75: 912-18.
132. Hu T, Khambatta ZS, Hayden PJ, et al,. Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol In Vitro 2010; 24: 1450-63.
133. Hayden PJ, Petrali JP, Stolper G, et al,. Microvesicating effects of sulfur mustard on an in vitro human skin model. Toxicol In Vitro 2009; 23: 1396-405.
134. Mallampati R, Patlolla RR, Agarwal S, et al,. Evaluation of EpiDerm full thickness-300 (EFT-300) as an in vitro model for skin irritation: studies on aliphatic hydrocarbons. Toxicol In Vitro 2010; 24: 669-76.
135. Black AT, Hayden PJ, Casillas RP, et al,. Expression of proliferative and inflammatory markers in a full-thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Toxicol Appl Pharmacol 2010; 249: 178-87.
136. Falanga V, Isaacs C, Paquette D, et al,. Wounding of bioengineered skin: cellular and molecular aspects after injury. J Invest Dermatol 2002; 119: 653-60.
137. Egles C, Garlick JA, Shamis Y,. Three-dimensional human tissue models of wounded skin. Methods Mol Biol 2010; 585: 345-59.
138. Sullivan TP, Eaglstein WH, Davis SC, Mertz P,. The pig as a model for human wound healing. Wound Repair Regen 2001; 9: 66-76.
139. Amendt C, Mann A, Schirmacher P, Blessing M,. Resistance of keratinocytes to TGFβ-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J Cell Sci 2002; 115: 2189-98.
140. Grose R, Hutter C, Bloch W, et al,. A crucial role of β1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development 2002; 129: 2303-15.
141. Yoshida S, Yamaguchi Y, Itami S, et al,. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. J Invest Dermatol 2003; 120: 335-43.
142. Mansbridge JN, Knapp AM,. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 1987; 89: 253-63.
143. Obeng MK, McCauley RL, Barnett JR, et al,. Cadaveric allograft discards as a result of positive skin cultures. Burns 2001; 27: 267-71.
144. Garfein ES, Orgill DP, Pribaz JJ,. Clinical applications of tissue engineered constructs. Clin Plast Surg 2003; 30: 485-98.
145. Hansen SL, Voigt DW, Wiebelhaus P, Paul CN,. Using skin replacement products to treat burns and wounds. Adv Skin Wound Care 2001; 14: 37-44.
146. Wisser D, Rennekampff HO, Schaller HE,. Skin assessment of burn wounds covered with a collagen based dermal substitute in a 2 year-follow-up. Burns 2004; 30: 399-401.
147. Still J, Glat P, Silverstein P, et al,. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 2003; 29: 837-41.
148. Hohlfeld J, de Buys Roessingh A, Hirt-Burri N, et al,. Tissue engineered fetal skin constructs for paediatric burns. Lancet 2005; 366: 840-2.
149. Ichioka S, Kouraba S, Sekiya N, et al,. Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg 2005; 58: 1124-30.
150. Vojtassak J, Danisovic L, Kubes M, et al,. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett 2006; 27 (Suppl. 2): 134-7.
151. Bernerd F, Asselineau D,. Successive alteration and recovery of epidermal differentiation and morphogenesis after specific UVB-damages in skin reconstructed in vitro. Dev Biol 1997; 183: 123-38.
152. Bernerd F, Asselineau D,. An organotypic model of skin to study photodamage and photoprotection in vitro. J Am Acad Dermatol 2008; 58: S155-9.
153. Bernerd F, Asselineau D,. UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ 1998; 5: 792-802.
154. Bessou S, Surléve-Bazeille JE, Sorbier E, Taïeb A,. Ex vivo reconstruction of the epidermis with melanocytes and the influence of UVB. Pigment Cell Res 1995; 8: 241-9.
155. Cario-André M, Bessou S, Gontier E, et al,. The reconstructed epidermis with melanocytes: a new tool to study pigmentation and photoprotection. Cell Mol Biol (Noisy-le-grand) 1999; 45: 931-42.
156. Javeri A, Huang XX, Bernerd F, et al,. Human 8-oxoguanine-DNA glycosylase 1 protein and gene are expressed more abundantly in the superficial than basal layer of human epidermis. DNA Repair (Amst) 2008; 7: 1542-50.
157. Kurdykowski S, Mine S, Bardey V, et al,. Ultraviolet-B irradiation induces epidermal up-regulation of heparanase expression and activity. J Photochem Photobiol, B 2012; 106: 107-12.
158. Fagot D, Asselineau D, Bernerd F,. Matrix metalloproteinase-1 production observed after solar-simulated radiation exposure is assumed by dermal fibroblasts but involves a paracrine activation through epidermal keratinocytes. Photochem Photobiol 2004; 79: 499-505.
159. Marionnet C, Pierrard C, Lejeune F, et al,. Different oxidative stress response in keratinocytes and fibroblasts of reconstructed skin exposed to non extreme daily-ultraviolet radiation. PLoS One 2010; 5: e12059.
160. Rezvani HR, Ged C, Bouadjar B, et al,. Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis. Cancer Gene Ther 2008; 15: 241-51.
161. Bernerd F, Vioux C, Asselineau D,. Evaluation of the protective effect of sunscreens on in vitro reconstructed human skin exposed to UVB or UVA irradiation. Photochem Photobiol 2000; 71: 314-20.
162. Monti D, Brini I, Tampucci S, et al,. Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat skin. Skin Pharmacol Physiol 2008; 21: 318-25.
163. Facy V, Flouret V, Régnier M, Schmidt R,. Reactivity of Langerhans cells in human reconstructed epidermis to known allergens and UV radiation. Toxicol In Vitro 2005; 19: 787-95.
164. Ponec M, Kempenaar J, Weerheim A,. Lack of desquamation-the Achilles heel of the reconstructed epidermis. Int J Cosmet Sci 2002; 24: 263-72.
165. Pageon H,. Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol Biol (Paris) 2010; 58: 226-31.
166. Pageon H, Zucchi H, Rousset F, et al,. Skin aging by glycation: lessons from the reconstructed skin model. Clin Chem Lab Med 2014; 52: 169-74.
167. Krishnamurthy J, Torrice C, Ramsey MR, et al,. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114: 1299-307.
168. Ressler S, Bartkova J, Niederegger H, et al,. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006; 5: 379-89.
169. Adamus J, Aho S, Meldrum H, et al,. p16INK4A influences the aging phenotype in the living skin equivalent. J Invest Dermatol 2014; 134: 1131-3.
170. Barker CL, McHale MT, Gillies AK, et al,. The development and characterization of an in vitro model of psoriasis. J Invest Dermatol 2004; 123: 892-901.
171. Amigo M, Schalkwijk J, Olthuis D, et al,. Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation. Life Sci 2006; 79: 2395-404.
172. Harrison CA, Layton CM, Hau Z, et al,. Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin. Br J Dermatol 2007; 156: 247-57.
173. Engelhart K, El Hindi T, Biesalski HK, Pfitzner I,. In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Arch Dermatol Res 2005; 297: 1-9.
174. Tjabringa G, Bergers M, van Rens D, et al,. Development and validation of human psoriatic skin equivalents. Am J Pathol 2008; 173: 815-23.
175. Jansen PA, Rodijk-Olthuis D, Hollox EJ, et al,. β-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS One 2009; 4: e4725.
176. Woodley DT, Krueger GG, Jorgensen CM, et al,. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 2003; 121: 1021-8.
177. Siprashvili Z, Nguyen NT, Bezchinsky MY, et al,. Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum Gene Ther 2010; 21: 1299-310.
178. Baldeschi C, Gache Y, Rattenholl A, et al,. Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet 2003; 12: 1897-905.
179. Rezvani HR, Kim AL, Rossignol R, et al,. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest 2011; 121: 195-211.
180. Bernerd F, Asselineau D, Frechet M, et al,. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light. Photochem Photobiol 2005; 81: 19-24.
181. Warrick E, Garcia M, Chagnoleau C, et al,. Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells. Mol Ther 2012; 20: 798-807.
182. Taïeb A, Picardo M,; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35.
183. Cario-André M, Pain C, Gauthier Y, Taïeb A,. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res 2007; 20: 385-93.
184. Ricard AS, Pain C, Daubos A, et al,. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol 2012; 21: 411-16.
185. Mestas J, Hughes CC,. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731-8.
186. Shay T, Jojic V, Zuk O, et al,. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci USA 2013; 110: 2946-51.
187. Davis MM,. A prescription for human immunology. Immunity 2008; 29: 835-8.
188. Chau DY, Johnson C, MacNeil S, et al,. The development of a 3D immunocompetent model of human skin. Biofabrication 2013; 5: 035011.
189. Thode C, Woetmann A, Wandall HH, et al,. Malignant T cells secrete galectins and induce epidermal hyperproliferation and disorganized stratification in a skin model of cutaneous T-cell lymphoma. J Invest Dermatol 2015; 135: 238-46.
190. van den Bogaard EH, Tjabringa GS, Joosten I, et al,. Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases. J Invest Dermatol 2014; 134: 719-27.
191. Botchkarev VA, Yaar M, Peters EM, et al,. Neurotrophins in skin biology and pathology. J Invest Dermatol 2006; 126: 1719-27.
192. Tominaga M, Tengara S, Kamo A, et al,. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 2009; 55: 40-6.
193. Yamaguchi J, Aihara M, Kobayashi Y, et al,. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009; 53: 48-54.
194. Harvima IT, Nilsson G, Naukkarinen A,. Role of mast cells and sensory nerves in skin inflammation. G Ital Dermatol Venereol 2010; 145: 195-204.